Cargando…

Diagnostic accuracy and validation of (18)F-fluorodeoxyglucose positron emission tomography scores in a large cohort of patients with polymyalgia rheumatica

BACKGROUND: Several studies have shown that (18)F-FDG PET may contribute to the diagnosis of polymyalgia rheumatica (PMR). Previously, we developed a composite PET score called the Leuven score, which was recently adapted to the more concise Leuven/Groningen score by van der Geest et al. The aim of...

Descripción completa

Detalles Bibliográficos
Autores principales: Moreel, Lien, Boeckxstaens, Lennert, Betrains, Albrecht, Van Hemelen, Maarten, Vanderschueren, Steven, Van Laere, Koen, Blockmans, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533121/
https://www.ncbi.nlm.nih.gov/pubmed/36213649
http://dx.doi.org/10.3389/fmed.2022.1026944
_version_ 1784802275132178432
author Moreel, Lien
Boeckxstaens, Lennert
Betrains, Albrecht
Van Hemelen, Maarten
Vanderschueren, Steven
Van Laere, Koen
Blockmans, Daniel
author_facet Moreel, Lien
Boeckxstaens, Lennert
Betrains, Albrecht
Van Hemelen, Maarten
Vanderschueren, Steven
Van Laere, Koen
Blockmans, Daniel
author_sort Moreel, Lien
collection PubMed
description BACKGROUND: Several studies have shown that (18)F-FDG PET may contribute to the diagnosis of polymyalgia rheumatica (PMR). Previously, we developed a composite PET score called the Leuven score, which was recently adapted to the more concise Leuven/Groningen score by van der Geest et al. The aim of this study is to validate and compare the diagnostic accuracy and cut-off points of both scores in a large cohort of PMR patients. METHODS: Patients with a possible clinical diagnosis of PMR and a PET scan prior to the initiation of glucocorticoids between 2003 and 2020 were included retrospectively. The gold standard for the diagnosis of PMR was the judgment of two experienced clinicians after a follow-up of at least 6 months. FDG uptake was scored visually in 12 articular regions (scores 0–2) and a total skeletal score was calculated by summing the individual scores (maximum of 24 for the Leuven score and 14 for the Leuven/Groningen score). Receiver operating characteristic (ROC) analysis and the Youden index were used to determine the diagnostic accuracy and optimal cut-off points. RESULTS: A total of 162 patients with PMR and 83 control patients were included. Both PET scores showed high diagnostic accuracy in the ROC analysis (area under the curve 0.986 and 0.980, respectively). The Leuven Score provided a sensitivity of 91.4%, specificity of 97.6% and accuracy of 93.5% at its predefined cut-off point of 16. With the newly determined cut-off point of 12 the sensitivity was 98.8%, the specificity 95.2% and the accuracy 97.6%. The Leuven/Groningen score had a sensitivity, specificity and accuracy of 93.2%, 95.2%, and 93.9%, respectively, with the pre-specified cut-off point of 8, and 96.9%, 92.8%, and 95.5% with the optimal cut-off point of 7. CONCLUSION: The original Leuven score and the simplified Leuven/Groningen score both had excellent diagnostic accuracy. The latter may be easier to apply in clinical practice.
format Online
Article
Text
id pubmed-9533121
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95331212022-10-06 Diagnostic accuracy and validation of (18)F-fluorodeoxyglucose positron emission tomography scores in a large cohort of patients with polymyalgia rheumatica Moreel, Lien Boeckxstaens, Lennert Betrains, Albrecht Van Hemelen, Maarten Vanderschueren, Steven Van Laere, Koen Blockmans, Daniel Front Med (Lausanne) Medicine BACKGROUND: Several studies have shown that (18)F-FDG PET may contribute to the diagnosis of polymyalgia rheumatica (PMR). Previously, we developed a composite PET score called the Leuven score, which was recently adapted to the more concise Leuven/Groningen score by van der Geest et al. The aim of this study is to validate and compare the diagnostic accuracy and cut-off points of both scores in a large cohort of PMR patients. METHODS: Patients with a possible clinical diagnosis of PMR and a PET scan prior to the initiation of glucocorticoids between 2003 and 2020 were included retrospectively. The gold standard for the diagnosis of PMR was the judgment of two experienced clinicians after a follow-up of at least 6 months. FDG uptake was scored visually in 12 articular regions (scores 0–2) and a total skeletal score was calculated by summing the individual scores (maximum of 24 for the Leuven score and 14 for the Leuven/Groningen score). Receiver operating characteristic (ROC) analysis and the Youden index were used to determine the diagnostic accuracy and optimal cut-off points. RESULTS: A total of 162 patients with PMR and 83 control patients were included. Both PET scores showed high diagnostic accuracy in the ROC analysis (area under the curve 0.986 and 0.980, respectively). The Leuven Score provided a sensitivity of 91.4%, specificity of 97.6% and accuracy of 93.5% at its predefined cut-off point of 16. With the newly determined cut-off point of 12 the sensitivity was 98.8%, the specificity 95.2% and the accuracy 97.6%. The Leuven/Groningen score had a sensitivity, specificity and accuracy of 93.2%, 95.2%, and 93.9%, respectively, with the pre-specified cut-off point of 8, and 96.9%, 92.8%, and 95.5% with the optimal cut-off point of 7. CONCLUSION: The original Leuven score and the simplified Leuven/Groningen score both had excellent diagnostic accuracy. The latter may be easier to apply in clinical practice. Frontiers Media S.A. 2022-09-21 /pmc/articles/PMC9533121/ /pubmed/36213649 http://dx.doi.org/10.3389/fmed.2022.1026944 Text en Copyright © 2022 Moreel, Boeckxstaens, Betrains, Van Hemelen, Vanderschueren, Van Laere and Blockmans. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Moreel, Lien
Boeckxstaens, Lennert
Betrains, Albrecht
Van Hemelen, Maarten
Vanderschueren, Steven
Van Laere, Koen
Blockmans, Daniel
Diagnostic accuracy and validation of (18)F-fluorodeoxyglucose positron emission tomography scores in a large cohort of patients with polymyalgia rheumatica
title Diagnostic accuracy and validation of (18)F-fluorodeoxyglucose positron emission tomography scores in a large cohort of patients with polymyalgia rheumatica
title_full Diagnostic accuracy and validation of (18)F-fluorodeoxyglucose positron emission tomography scores in a large cohort of patients with polymyalgia rheumatica
title_fullStr Diagnostic accuracy and validation of (18)F-fluorodeoxyglucose positron emission tomography scores in a large cohort of patients with polymyalgia rheumatica
title_full_unstemmed Diagnostic accuracy and validation of (18)F-fluorodeoxyglucose positron emission tomography scores in a large cohort of patients with polymyalgia rheumatica
title_short Diagnostic accuracy and validation of (18)F-fluorodeoxyglucose positron emission tomography scores in a large cohort of patients with polymyalgia rheumatica
title_sort diagnostic accuracy and validation of (18)f-fluorodeoxyglucose positron emission tomography scores in a large cohort of patients with polymyalgia rheumatica
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533121/
https://www.ncbi.nlm.nih.gov/pubmed/36213649
http://dx.doi.org/10.3389/fmed.2022.1026944
work_keys_str_mv AT moreellien diagnosticaccuracyandvalidationof18ffluorodeoxyglucosepositronemissiontomographyscoresinalargecohortofpatientswithpolymyalgiarheumatica
AT boeckxstaenslennert diagnosticaccuracyandvalidationof18ffluorodeoxyglucosepositronemissiontomographyscoresinalargecohortofpatientswithpolymyalgiarheumatica
AT betrainsalbrecht diagnosticaccuracyandvalidationof18ffluorodeoxyglucosepositronemissiontomographyscoresinalargecohortofpatientswithpolymyalgiarheumatica
AT vanhemelenmaarten diagnosticaccuracyandvalidationof18ffluorodeoxyglucosepositronemissiontomographyscoresinalargecohortofpatientswithpolymyalgiarheumatica
AT vanderschuerensteven diagnosticaccuracyandvalidationof18ffluorodeoxyglucosepositronemissiontomographyscoresinalargecohortofpatientswithpolymyalgiarheumatica
AT vanlaerekoen diagnosticaccuracyandvalidationof18ffluorodeoxyglucosepositronemissiontomographyscoresinalargecohortofpatientswithpolymyalgiarheumatica
AT blockmansdaniel diagnosticaccuracyandvalidationof18ffluorodeoxyglucosepositronemissiontomographyscoresinalargecohortofpatientswithpolymyalgiarheumatica